Zogenix (NASDAQ:ZGNX)‘s stock had its “buy” rating reaffirmed by equities researchers at Brean Capital in a research report issued to clients and investors on Friday, Market Beat Ratings reports. They presently have a $28.00 price target on the stock. · 8/16/2015
Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, announced today that at the annual general meeting of shareholders held earlier today …
StreetInsider · 6/18/2015
These fundamental strengths along with likely buyout speculation should propel ZGNX stock back over $6.00 for a healthy 3-bagger gain. For those reasons (and more to come in a second ZGNX article), Zogenix is my top biotech pick for 2012.
Seeking Alpha · 1/3/2012
Zogenix Inc (NASDAQ: ZGNX), Quepasa Corporation (NYSE: QPSA), and Unilife Corp (NASDAQ: UNIS) are some such stocks which have come off in the recent days but are otherwise recommended highly by analysts and generally have more than one …
Smallcap Network · ByBrian Prescott · 3/1/2012
The stock market was up and down all day on Wednesday. It is volatile and tradable, but a tough market. Let’s take a look at some of the stocks that are still doing well, or did well on Wednesday. A10 Networks Inc. (NYSE:ATEN) is one of our swing trades. · 8/13/2015
The following stocks are peaking at new 52-week highs on July 15, 2015: ZGNX, RCPT, REPH, APPF, M, CELG, IDI Receptos Inc. (RCPT) has posted a new high of 230.10 above a previous 52 week high of 207.61. The company traded at $229.47 + 22.29 …
Fx Pips · 7/16/2015
The agency said it approved the Zogenix (NASDAQ:ZGNX, Stock Forum) pill Zohydro for patients with pain that requires, daily, around-the-clock treatment that cannot be addressed with other drugs. The approval comes as a surprise since the agency's own …
Stockhouse · 10/26/2013
Oct 28, 2013 (ACCESSWIRE via COMTEX) -- New York, NY - (ACCESSWIRE) - 10/28/2013 - Equity Profile Report initiates its Health-care Active Stock Watch List adding Synta Pharmaceuticals Corp. SNTA, -3.24% Dendreon Corp. DNDN Zogenix, Inc.
Market Watch · 10/28/2013
Investors that carve out part of their investment capital for these top stocks to buy may be in for a solid start to the new ... Zogenix Inc. (NASDAQ: ZGNX) is a top name to buy at Oppenheimer for 2014. The FDA recently approved its top new drug Zohydro.
24/7 Wall ST · 12/27/2013
While DSW Inc. (DSW) Stock Remains In Red, Company Announces Opening Of New Stores PUBLISHED: Aug 29, 2015 at 10:33 am EST DSW Inc stock has been closing in red during the week. However, the company has announced the opening of new … · 8/29/2015